Table 2

Study Visits
Visit 1 Daily Visit 2 Visit 3 Visit 4 Weekly Phone Calls Visit 5
Screening (within 60 days of baseline) Days (−7 to 70) Baseline Week 0 Week 3 Week 6 Week (−1, 1–2, 4–5 & 7–9) Week 10
Laboratory Values 1 X
Medical Exam/History/Socio-demographics X
Urine Pregnancy Test 1 X
PRIME-MD2 X
HADS 2 X X X
BFI 2 X X X X X X
Concomitant Medication & Supplements X
Sleep Diary X X
Group Randomization 3 X
Actiwatch Data Collected X X4 X4 X4 X4
LTQL X X X
BSAPQ 2 X X X X
GSE 2 X X X
BPI2 X X X X
Study Logbook X X X X X
PSQI 2 X X X
VAS for Pain 2 X
Berlin Questionnaire X
Therapy Evaluation Questionnaire X X
Perform Acupressure 5 X X X
Assess Treatment Fidelity – Self efficacy Measure X X
Adverse Events X X X X
Assessment of Blinding X

1 Complete Blood Count; blood for correlative tests, blood for future DNA analysis, Urine pregnancy test as appropriate.

2 HADS = Hospital Anxiety Depression Scale; BFI = Brief Fatigue Inventory; and PSQI = Pittsburgh Sleep Quality Index; LTQL = Long Term Quality of Life Instrument; BSAPQ = Breast and Surrounding Areas Pain Questionnaire; GSE = General Self Efficacy Scale; BPI = Brief Pain Inventory; VAS for Pain = Visual Analog; PRIME-MD = Primary Care Evaluation of Mental Disorders.

3 Participants are randomized to one of three treatments: Standard of Care; Relaxation Acupressure; or Stimulating Acupressure.

4 Data file downloaded at these visits.

5 Does not apply to standard of care arm.

Zick et al.

Zick et al. BMC Complementary and Alternative Medicine 2012 12:132   doi:10.1186/1472-6882-12-132

Open Data